Skip to main content
Acta Crystallographica Section F: Structural Biology Communications logoLink to Acta Crystallographica Section F: Structural Biology Communications
. 2014 May 10;70(Pt 6):697–702. doi: 10.1107/S2053230X14007341

Structure of a His170Tyr mutant of thermostable pNPPase from Geobacillus stearothermophilus

Tiantian Shen a, Zheng Guo a, Chaoneng Ji a,b,*
PMCID: PMC4051519  PMID: 24915075

The crystal structure of the His170Tyr mutant of thermostable pNPPase from Geobacillus stearothermophilus has been determined at 2.0 Å resolution, with Na+ and SO4 2− bound in the active site, showing a half-closed cap conformation.

Keywords: thermostability, TpNPPase, directed evolution, random mutagenesis

Abstract

Using directed evolution based on random mutagenesis and heat-treated selection, a thermostable His170Tyr mutant of Geobacillus stearothermophilus thermostable p-nitrophenylphosphatase (TpNPPase) was obtained. The temperature at which the His170Tyr mutant lost 50% of its activity (T 1/2) was found to be 4.40 K higher than that of wild-type TpNPPase, and the melting temperature of the His170Tyr mutant increased by 2.39 K. The crystal structure of the His170Tyr mutant was then determined at 2.0 Å resolution in the presence of a sodium ion and a sulfate ion in the active site. The cap domain of chain B shows a half-closed conformation. The hydrophobic side chain of the mutated residue, the hydroxyphenyl group, forms a hydrophobic contact with the methyl group of Ala166. This hydrophobic interaction was found using the Protein Interactions Calculator (PIC) web server with an interaction distance of 4.6 Å, and might be a key factor in the thermostabilization of the His170Tyr mutant. This study potentially offers a molecular basis for both investigation of the catalytic mechanism and thermostable protein engineering.

1. Introduction  

Thermostable p-nitrophenylphosphatase (TpNPPase) is an Mg2+-dependent enzyme involved in the hydrolysis of p-nitrophenylphos­phate (pNPP). It has an optimum reaction temperature of 328 K and a half-activity retention temperature (T 1/2) of 325 K (Li et al., 2003). The single ester bond of pNPP is cleaved by TpNPPase in the reaction, yielding phosphate and p-nitrophenol (pNP). pNP is yellow-coloured with an absorbance maximum at 405 nm. The enzyme is widely applied in nucleotide labelling and enzyme-linked immunosorbent assays. As a member of the haloalkanoate dehalogenase superfamily (HADSF) II-A subfamily, TpNPPase has a highly conserved α/β core domain consisting of four catalytic motifs: motifs I–IV. The nucleophilic Asp10 in motif I attacks the organophosphate and forms the aspartylphosphate intermediate, while another residue in motif I, Asp12 (the Asp+2 residue), is involved in general acid/base catalysis (Lu et al., 2008). Thr43 in motif II assists in substrate binding through hydrogen bonding (Zhang et al., 2004). Lys181 in motif III orients the nucleophile (Tremblay et al., 2006), and motif IV (Asp206) functions in the coordination of Mg2+ (Zhang et al., 2004). The subfamilies are also defined based on the presence and the location of a cap domain. The substrate-specificity loop, motif V, usually belongs to the cap domain (Tremblay et al., 2006).

Enzymes from the same family commonly share a high level of structural similarity. However, they may exhibit totally different thermostabilities. Thermostable proteins usually have important biotechnological advantages in purification methods, reaction rates and resistance to chemical denaturants (Becker et al., 1997). Additional intra-protein interactions usually contribute to protein thermostability, such as hydrophobic interactions and networks (You et al., 2010; Gromiha et al., 2013; Kim et al., 2012), hydrogen bonds and ionic pairs (Vogt et al., 1997; Matsui & Harata, 2007), disulfide bridges (Yang et al., 2007), salt bridges (Chan et al., 2011), aromatic clusters (Puchkaev et al., 2003) and cation–π interactions (Matsumura et al., 2007). An optimized conformational structure of proteins also plays an important role in enhancing thermostability, such as increased rigidity and decreased flexibility (Radestock & Gohlke, 2008, 2011), better packing (Fleming & Richards, 2000), more stable α-helices and fewer cavities (Kumar et al., 2000; Li et al., 2005), deletion or shortening of loops (Russell et al., 1997) and oligomerization (Tanaka et al., 2004). In previous studies, X-ray diffraction of TpNPPase crystals was reported by Ji et al. (2003) and the crystal structure was then determined by Guo et al. (2013). Comparisons between the structures of TpNPPase and several thermolabile HADSF members were performed in order to demonstrate the possible favourable structural factors for protein thermostability. TpNPPase contains more leucines and additional aromatic pairs than its thermolabile homologues, and stabilizing the cap domain is also beneficial for enhancing the thermostability of HASDF enzymes (Guo et al., 2013).

Identifying the molecular mechanisms involved in the stability of thermophilic proteins is valuable for protein engineering in both the scientific and industrial fields. Directed revolution based on random mutagenesis is a powerful and frequently used approach for investigation of the mechanisms of protein thermostability (Shionyu-Mitsuyama et al., 2005; Shi et al., 2008; Goto et al., 2008; Stephens et al., 2009; Ben Mabrouk et al., 2013). Since a large number of mutants with either increased or decreased thermostabilities can be obtained and analyzed systematically, the moderate thermostability of TpNPPase makes it an ideal subject for study of the mechanism of protein thermostabilization. In this study, we report the X-ray structure of the His170Tyr mutant protein, which was obtained by directed evolution, with improved thermostability.

2. Materials and methods  

2.1. Random mutagenesis and screening strategy of mutants  

Random mutagenesis of TpNPPase was performed by error-prone PCR. The primers 5′-GGCGTATCACGAGGCCCTTTCG-3′ and 5′-GATGGAGTTCTGAGGTCATTACTGG-3′ flanked by BamHI and HindIII restriction sites were used as the forward and reverse primers, respectively. PCR was carried out in a 50 µl reaction mixture containing dUTP, which was designed to increase the error frequency. The mixture was incubated at 356 K for 5 min followed by 30 cycles of 30 s at 367 K, 1 min at 323 K and 1 min at 345 K and a final extension at 345 K for 7 min. The mutagenic PCR products were purified using an AxyPrep DNA Gel Extraction Kit (Axygen) from a 1% TAE agarose gel. The gene was then cloned into the expression vector pQE_30a and expressed in the Escherichia coli M15 strain (Qiagen).

The mutants of TpNPPase were obtained based on the in situ colour screening method reported by Shu et al. (2002). E. coli M15 cells with a random mutagenesis DNA library were incubated on LB agar plates containing 50 µg ml−1 ampicillin, 50 µg ml−1 kanamycin and 0.04 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) overnight at 310 K. The bacterial colonies were transferred to filter papers wetted with 50 mM Tris–HCl pH 10.0 and incubated at 333 K for 10 min. After incubation, the filter papers were then moved to activity-indicator plates (containing 50 mM Tris–HCl pH 10.0, 1 mM MgCl2 and 5 mM pNPP) and incubated at 328 K for a further 5 min. Under these conditions, wild-type TpNPPase was mostly heat-inactivated and could not produce the yellow-coloured nitrophenolate. In this way, positive colonies with enhanced thermostability were selected by their colour. The mutants were identified by DNA sequencing.

2.2. Protein expression and purification  

An approximately 10 ml LB culture of recombinant E. coli M15 was incubated overnight at 310 K in the presence of ampicillin (50 µg ml−1) and kanamycin (50 µg ml−1) and was then transferred into 1 l LB medium with ampicillin (50 µg ml−1) and kanamycin (50 µg ml−1). The bacterial culture was induced with 1 mM IPTG when the OD600 reached 0.6–0.8, followed by 4 h incubation at 301 K.

The induced cells were harvested by centrifugation and lysed by pressure (JN-3000 Plus, JNBio, People’s Republic of China) at 277 K in the presence of 50 mM sodium phosphate pH 8.0, 300 mM NaCl and 10 mM imidazole. The mutant enzyme was harvested by centrifugation at 15 000 rev min−1 (Rotor No. R20A2, Hitachi) for 30 min at 277 K.

The six-His-tagged mutant was then purified on an Ni–NTA Superflow column (Qiagen) following a protocol with a linear imidazole elution gradient (10–250 mM) in 50 mM sodium phosphate, 300 mM NaCl pH 8.0. The obtained protein was further purified by gel filtration using a Superdex 75 column (GE Healthcare, USA) equilibrated with buffer consisting of 20 mM Tris–HCl pH 8.0, 200 mM NaCl. The pure His170Tyr mutant protein was dialyzed against Milli-Q water and concentrated to 30 mg ml−1 using a 10 kDa centrifugal filter (Millipore). The concentrated protein was flash-cooled in liquid nitrogen and maintained at 193 K until crystallization. The tag was not removed during the purification and crystallization steps.

2.3. Thermostability measurements  

The thermostabilities of TpNPPase and the His170Tyr mutant were estimated by determining both the melting temperature (T m) and the temperature at which 50% phosphatase activity was retained after 15 min incubation (T 1/2).

2.3.1. Residual phosphatase activies  

The reaction buffer contained 50 mM Tris–HCl pH 10.0, 1 mM MgCl2 and 5 mM pNPP. Enzymes were incubated for 15 min at various temperatures ranging from 293 to 338 K. After the enzymes had been cooled on ice, their residual phosphatase activities were examined according to the method described by Guo et al. (2013). Fitting of the collected data and calculation of T 1/2 were performed using GraphPad Prism 6.

2.3.2. Circular dichroism  

The T m values of native and mutant TpNPPase were compared by circular-dichroism spectroscopy (Jasco J-815). Proteins were diluted to 0.3 mg ml−1 in 10 mM PBS pH 8.0. Temperature-induced denaturation (313–353 K) was determined by stepped ramping in 2 K increments in a 0.1 cm path-length cuvette, and ellipticity data of the enzymes were collected in the UVCD band (200–230 nm). Thermal denaturation curves were fitted to a two-state model as described by Borgo & Havranek (2012). Calculation of T m was performed using Origin 8.

2.4. Crystallization and X-ray data collection  

The preliminary crystallization conditions of the His170Tyr mutant were screened by sitting-drop and hanging-drop vapour diffusion at 293 K using Crystal Screen HT and Index HT (Hampton Research, USA). Crystals were obtained by mixing 1.2 µl protein solution with 1.2 µl reservoir solution, which consisted of 0.1 M HEPES pH 8.0, 1.9 M ammonium sulfate, 3%(w/v) polyethylene glycol 400 (PEG 400). The droplets were equilibrated against 500 µl reservoir solution.

Prior to data collection, the single crystal was soaked in mother liquor containing 30%(v/v) glycerol as a cryoprotectant solution and was flash-cooled directly in a liquid-nitrogen stream. The X-ray diffraction data were collected on beamline BL17U-MX at Shanghai Synchrotron Radiation Facility using a MAR DTB detector system. The X-ray wavelength was 0.979 Å. The exposure time was 0.8 s per frame with a crystal-to-detector distance of 280 mm. A complete data set was obtained by collecting 180 images with 1° oscillation. Integration and scaling of diffraction intensities were performed using the HKL-2000 software suite (Otwinowski & Minor, 1997).

2.5. Structure determination  

The crystal structure of the mutant was determined by molecular replacement using the CCP4 suite of crystallographic programs (Winn et al., 2011). The structure of wild-type TpNPPase (PDB entry 4kn8; Guo et al., 2013) was used as the search model. Refinement was carried out using PHENIX v.1.8.2-1309 (Terwilliger et al., 2009) and manual fitting of side chains was performed in Coot (Emsley & Cowtan, 2004). The quality of the coordinates was validated using PROCHECK (Laskowski et al., 1993). The structural figures were generated by PyMOL (DeLano, 2004).

3. Results and discussion  

A thermostable mutant of TpNPPase, His170Tyr, was obtained through three rounds of random mutagenesis and one round of heat-treated selection. The T 1/2 and T m of the mutant and the wild-type TpNPPase were then evaluated to determine their thermostabilities. The T 1/2 value of the His170Tyr mutant increased by 4.40 K (Supplementary Fig. S11) and the T m value increased by 2.39 K (Supplementary Fig. S2).

The His170Tyr mutant crystallized in space group P212121 with two monomers in the asymmetric unit. The final model of the His170Tyr mutant was refined in the resolution range 40.5–2.0 Å to a crystallographic R work value of 17.1% and an R free value of 21.3%. Na+ and SO4 2− ions were built into the structure with reasonable B factors (Fig. 1). After refinement, the final B factors of Na+ and SO4 2− were 20.95 and 32.14 Å2, respectively. A summary of the data-collection and refinement statistics is presented in Table 1. The overall structure of the His170Tyr mutant showed high similarity to that of wild-type TpNPPase (PDB entry 4kn8; Guo et al., 2013), with a root-mean-square deviation of only 0.184 Å over all Cα atoms.

Figure 1.

Figure 1

(a) Overall structure of the His170Tyr mutant (grey) in cartoon representation, with side chains of the active site and the SO4 2− ion shown as sticks. The Na+ ion (purple) is represented as a sphere. The electron density of the Na+ and SO4 2− ions is shown (contoured at 2.0σ). (b) A closer view of the active site. Polar contacts are shown as dashed lines. The average M +⋯O distance for Na+ is 2.4 Å.

Table 1. Data-collection and refinement statistics.

Values in parentheses are for the highest resolution shell.

Data collection and processing
X-ray source BL17U-MX
Wavelength () 0.9792
Space group P212121
Unit-cell parameters (, ) a = 38.75, b = 83.25, c = 176.05, = = = 90
Resolution () 40.52.0 (2.072.00)
Total reflections 206742
Unique reflections 39405
Multiplicity 5.2
Completeness (%) 97.86 (90.38)
Mean I/(I) 13.46 (4.56)
R merge (%) 9.0 (47.6)
Solvent content (%) 49.79
Refinement
No. of molecules in asymmetric unit 2
R work (%) 17.10 (16.56)
R free (%) 21.34 (23.33)
No. of atoms
Protein 3978
Ligand 6
Water 258
R.m.s.d.
Bonds () 0.011
Angles () 1.23
Average B factor (2) 22.60
Ramachandran statistics (%)
Most favoured 94.4
Generously allowed 5.6
Disallowed 0
PDB code 4o8c

In wild-type TpNPPase residues 18–22 of chain B were not modelled owing to poor electron density, indicating that this loop might be quite flexible, whereas in the His170Tyr mutant this loop was successfully built with sufficient electron density (Fig. 2). Superimposition of the structures shows that the sulfate ion in the His170Tyr mutant occupies the position of the side chain of Asp12 in the wild type (Fig. 3). Owing to steric hindrance, the side chain of Asp12 is oriented away from the substrate-binding site. A polar contact is formed between Asp12 and Gly18 (2.3 Å) after side-chain rotation. This polar interaction probably helps to stabilize the conformation of the flexible loop.

Figure 2.

Figure 2

(a) Residues 18–22 of the His170Tyr mutant shown in cartoon representation. The electron-density map of residues 18–22 is shown (contoured at 2.0σ). SO4 2−, Asp12 and Gly18 are shown as sticks. Polar contact between Asp12 and Gly18 is shown as a dashed line. (b) Residues 18–22 are not visible in the structure of wild-type TpNPPase.

Figure 3.

Figure 3

Superimposition of the active sites of wild-type TpNPPase (violet), the His170Tyr mutant (blue) and PLPP (green).

Like most HADSF subclass II members, the core domain of TpNPPase lacks the ability to close off the active site from solvent. Residues 72–172 form a cap domain, the main functions of which may be substrate recognition and active-site desolvation. The cap and core domains move by a hinge-like motion to open/close the active site in response to substrate binding (Tremblay et al., 2006). In the previous study, the structure of wild-type TpNPPase was only determined in a cap-open conformation (Guo et al., 2013). As a result, this study uses human pyridoxal 5′-phosphate phosphatase (PLPP), a member of the HAD-like hydrolase superfamily, as an alternative for comparison. The structure of human PLPP was determined in a cap-closed conformation in complex with its substrate PLP (PDB entry 2cft; B. S. Kang, H. J. Cho, K. J. Kim & O. S. Kwon, unpublished work), and shares 26% sequence identity with TpNPPase in a homological comparison of amino acids (Supplementary Fig. S3). Compared with the wild-type TpNPPase and the cap-closed human PLPP, chain B of the His170Tyr mutant displays a half-closed conformation (Fig. 4). Superimposition of the active sites of these three structures was performed in PyMOL (Fig. 3). The active site of the His170Tyr mutant superimposed much better on the structure of PLPP (r.m.s.d. of residues = 0.432 Å) than on that of wild-type TpNPPase (r.m.s.d. of residues = 1.211 Å). The half-closed conformation discovered in chain B is a new state which might be the transition state of the cap domain. The orientation of SO4 2− is highly similar to that of PLP, indicating that chain B of the His170Tyr mutant may reflect the structure of TpNPPase in complex with coenzyme and substrate. The structure offers a molecular basis to deepen understanding of the catalytic mechanism of TpNPPase, and further investigation into the mechanism would require more experimental evidence.

Figure 4.

Figure 4

Conformational comparison of the cap domain. (a) The cap-open conformation of wild-type TpNPPase (PDB entry 4kn8; Guo et al., 2013). (b) Complex structure of the His170Tyr mutant with Na+ and SO4 2−, showing a half-closed conformation. Na+ and SO4 2− are represented by a red sphere and as sticks, respectively. (c) Complex structure of PLPP with substrate in the cap-closed conformation (PDB entry 2cft; B. S. Kang, H. J. Cho, K. J. Kim & O. S. Kwon, unpublished work). Ca2+ and PLP are shown as a red sphere and as sticks, respectively.

In both the T m and T 1/2 assays, the His170Tyr mutant showed an increased thermostability compared with the wild type. The mutated residue, His170/Tyr170, is positioned near the C-terminus on the seventh strand of the α-helix of TpNPPase with its side chain exposed to the solvent (Fig. 5 a). The hydrophilic residue (His) was mutated to a hydrophobic aromatic residue (Tyr). The orientations of Tyr170 and His170 were similar (Fig. 5 b). However, an additional hydrophobic interaction between Ala166 and Tyr170 was observed using the Protein Interactions Calculator (PIC) web server (Tina et al., 2007). The average distance of 4.6 Å (within 5 Å) between the two hydrophobic side chains, the methyl group of Ala166 and the hydroxy­phenyl group of Tyr170, is close enough to form a hydrophilic contact which helps to stabilize the secondary structure of the α-helix, a possible indication of functional molecular folding and improved thermostability. Thus, the authors believe that the hydrophobic contact formed by Ala166 and Tyr170 is the main factor which enhances the thermostability of TpNPPase.

Figure 5.

Figure 5

(a) The mutation occurs near the seventh strand of the α-helix of TpNPPase with its side chain exposed to the solvent. (b) Crystal structures of His170Tyr mutant (blue) and wild-type TpNPPase (green) at the mutation position.

Supplementary Material

PDB reference: TpNPPase, His170Tyr mutant, 4o8c

Supporting Information.. DOI: 10.1107/S2053230X14007341/hv5255sup1.pdf

f-70-00697-sup1.pdf (289.1KB, pdf)

Acknowledgments

This work was supported by the National Basic Research Program of China (973 Program, 2009CB825505), the National Natural Science Foundation of China (30770427) and the Shanghai Science and Technology Commission (13DZ2252000). The X-ray data collection was performed on beamline BL17U-MX at Shanghai Synchrotron Radiation Facility (SSRF; Shanghai, People’s Republic of China). We would like to thank Wei Li, Rui Qiu, Fengbin Wang and the staff at SSRF for their assistance and suggestions.

Footnotes

1

Supporting information has been deposited in the IUCr electronic archive (Reference: HV5255).

References

  1. Becker, P., Abu-Reesh, I., Markossian, S., Antranikian, G. & Märkl, H. (1997). Appl. Microbiol. Biotechnol. 48, 184–190. [DOI] [PubMed]
  2. Ben Mabrouk, S., Ayadi, D. Z., Ben Hlima, H. & Bejar, S. (2013). J. Biotechnol. 168, 601–606. [DOI] [PubMed]
  3. Borgo, B. & Havranek, J. J. (2012). Proc. Natl Acad. Sci. USA, 109, 1494–1499. [DOI] [PMC free article] [PubMed]
  4. Chan, C.-H., Yu, T.-H. & Wong, K.-B. (2011). PLoS One, 6, e21624. [DOI] [PMC free article] [PubMed]
  5. DeLano, W. L. (2004). Abstr. Pap. Am. Chem. Soc. 228, 030-CHED.
  6. Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. [DOI] [PubMed]
  7. Fleming, P. J. & Richards, F. M. (2000). J. Mol. Biol. 299, 487–498. [DOI] [PubMed]
  8. Goto, T., Ohkuri, T., Shioi, S., Abe, Y., Imoto, T. & Ueda, T. (2008). J. Biochem. 144, 619–623. [DOI] [PubMed]
  9. Gromiha, M. M., Pathak, M. C., Saraboji, K., Ortlund, E. A. & Gaucher, E. A. (2013). Proteins, 81, 715–721. [DOI] [PubMed]
  10. Guo, Z., Wang, F., Shen, T., Huang, J., Wang, Y. & Ji, C. (2013). Protein Pept. Lett. 21, 483–489. [DOI] [PubMed]
  11. Ji, C.-N., Tian, L., Feng, C.-J., Yin, G., Shu, G., Li, J.-X., Gong, W.-M., Pang, H., Xie, Y. & Mao, Y.-M. (2003). Protein Pept. Lett. 10, 521–524. [DOI] [PubMed]
  12. Kim, T., Joo, J. C. & Yoo, Y. J. (2012). J. Biotechnol. 161, 49–59. [DOI] [PubMed]
  13. Kumar, S., Tsai, C.-J. & Nussinov, R. (2000). Protein Eng. 13, 179–191. [DOI] [PubMed]
  14. Laskowski, R. A., Moss, D. S. & Thornton, J. M. (1993). J. Mol. Biol. 231, 1049–1067. [DOI] [PubMed]
  15. Li, J., Feng, C., Ji, C., Li, Y., Yang, Q., Tian, L., Xie, Y. & Mao, Y. (2003). J. Fudan Univ. (Nat. Sci.), 42, 584–587.
  16. Li, W. F., Zhou, X. X. & Lu, P. (2005). Biotechnol. Adv. 23, 271–281. [DOI] [PubMed]
  17. Lu, Z., Dunaway-Mariano, D. & Allen, K. N. (2008). Proc. Natl Acad. Sci. USA, 105, 5687–5692. [DOI] [PMC free article] [PubMed]
  18. Matsui, I. & Harata, K. (2007). FEBS J. 274, 4012–4022. [DOI] [PubMed]
  19. Matsumura, H., Yamamoto, T., Leow, T. C., Mori, T., Salleh, A. B., Basri, M., Inoue, T., Kai, Y. & Rahman, R. N. Z. R. A. (2007). Proteins, 70, 592–598. [DOI] [PubMed]
  20. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 301–326. [DOI] [PubMed]
  21. Puchkaev, A. V., Koo, L. S. & Ortiz de Montellano, P. R. (2003). Arch. Biochem. Biophys. 409, 52–58. [DOI] [PubMed]
  22. Radestock, S. & Gohlke, H. (2008). Eng. Life Sci. 8, 507–522.
  23. Radestock, S. & Gohlke, H. (2011). Proteins, 79, 1089–1108. [DOI] [PubMed]
  24. Russell, R. J. M., Ferguson, J. M. C., Hough, D. W., Danson, M. J. & Taylor, G. L. (1997). Biochemistry, 36, 9983–9994. [DOI] [PubMed]
  25. Shi, C., Lu, X., Ma, C., Ma, Y., Fu, X. & Yu, W. (2008). Appl. Biochem. Biotechnol. 151, 51–59. [DOI] [PubMed]
  26. Shionyu-Mitsuyama, C., Ito, Y., Konno, A., Miwa, Y., Ogawa, T., Muramoto, K. & Shirai, T. (2005). J. Mol. Biol. 347, 385–397. [DOI] [PubMed]
  27. Shu, G., Ji, C. N., Jiang, T., Ma, Y. H., Yin, G., Xie, Y. & Mao, Y. M. (2002). J. Fudan Univ. (Nat. Sci.), 41, 710–713.
  28. Stephens, D. E., Singh, S. & Permaul, K. (2009). FEMS Microbiol. Lett. 293, 42–47. [DOI] [PubMed]
  29. Tanaka, Y., Tsumoto, K., Yasutake, Y., Umetsu, M., Yao, M., Fukada, H., Tanaka, I. & Kumagai, I. (2004). J. Biol. Chem. 279, 32957–32967. [DOI] [PubMed]
  30. Terwilliger, T. C., Adams, P. D., Read, R. J., McCoy, A. J., Moriarty, N. W., Grosse-Kunstleve, R. W., Afonine, P. V., Zwart, P. H. & Hung, L.-W. (2009). Acta Cryst. D65, 582–601. [DOI] [PMC free article] [PubMed]
  31. Tina, K. G., Bhadra, R. & Srinivasan, N. (2007). Nucleic Acids Res. 35, W473–W476. [DOI] [PMC free article] [PubMed]
  32. Tremblay, L. W., Dunaway-Mariano, D. & Allen, K. N. (2006). Biochemistry, 45, 1183–1193. [DOI] [PubMed]
  33. Vogt, G., Woell, S. & Argos, P. (1997). J. Mol. Biol. 269, 631–643. [DOI] [PubMed]
  34. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
  35. Yang, H. M., Yao, B., Meng, K., Wang, Y. R., Bai, Y. G. & Wu, N. F. (2007). J. Ind. Microbiol. Biotechnol. 34, 213–218. [DOI] [PubMed]
  36. You, C., Huang, Q., Xue, H., Xu, Y. & Lu, H. (2010). Biotechnol. Bioeng. 105, 861–870. [DOI] [PubMed]
  37. Zhang, G., Morais, M. C., Dai, J., Zhang, W., Dunaway-Mariano, D. & Allen, K. N. (2004). Biochemistry, 43, 4990–4997. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

PDB reference: TpNPPase, His170Tyr mutant, 4o8c

Supporting Information.. DOI: 10.1107/S2053230X14007341/hv5255sup1.pdf

f-70-00697-sup1.pdf (289.1KB, pdf)

Articles from Acta Crystallographica. Section F, Structural Biology Communications are provided here courtesy of International Union of Crystallography

RESOURCES